• Study of Venetoclax and Azacitidine for Maintenance Therapy in Patients with Acute Myeloid Leukemia in First Remission After Chemotherapy

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Greece Hungary Italy +1

  • Study on the Safety of A24110He for Patients with Type 2 Diabetes and High Triglycerides

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study on the Safety and Pharmacokinetics of Risdiplam in Infants with Spinal Muscular Atrophy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Italy The Netherlands Norway Poland

  • Study on Long-term Safety and Effects of ARGX-117 for Adults with Multifocal Motor Neuropathy

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Germany Italy The Netherlands +2

  • Study on the Effects of Pariglasgene Brecaparvovec for Adults with Glycogen Storage Disease Type Ia

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands Spain

  • Study of TransCon TLR7/8 Agonist, TransCon IL-2 β/γ, and Pembrolizumab for Patients with Advanced Head and Neck Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Hungary Italy Poland Spain

  • Study on Siplizumab and Rabbit Anti-Thymocyte Globulin for Preventing Rejection in New Kidney Transplant Patients

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Austria Spain Sweden

  • Study on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia France Germany Greece Ireland +3

  • Study on the Safety and Effects of THOR-707 and Drug Combination in Adults with Advanced or Metastatic Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Hungary Poland

powered by